Complex generic first to show ‘virtual’ bioequivalence with Certara’s modeling system

FDA's approval of an undisclosed complex generic via the ANDA pathway marks the first use of Certara's modeling

Read the full 184 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE